InvestorsHub Logo

02opida

04/07/24 7:58 AM

#616458 RE: 02opida #616457

AMRN - New REDUCE-IT(TM) Analyses Show VASCEPA(TM)/VAZKEPA(TM) (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups